Startups around the world are engaging in clinical trials in a sector that could change lives – and be worth more than £15bn by the 2030s
Oran Knowlson, a British teenager with a severe type of epilepsy called Lennox-Gastaut syndrome, became the first person in the world to trial a new brain implant last October, with phenomenal results – his daytime seizures were reduced by 80%.
“It’s had a huge impact on his life and has prevented him from having the falls and injuring himself that he was having before,” says Martin Tisdall, a consultant paediatric neurosurgeon at Great Ormond Street Hospital (Gosh) in London, who implanted the device. “His mother was talking about how he’s had such a improvement in his quality of life, but also in his cognition: he’s more alert and more engaged.”
About Author
More Stories
As a geneticist, I will not mourn 23andMe and its jumble of useless health information | Adam Rutherford
Trump extends deadline for TikTok sale to non-Chinese buyer to avoid ban
Which celebrities are lying about their height? This website’s done the research